Microbot Medical Inc. (MBOT) stock
Close on Nov 13, 2026Market cap $65.73MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $65.73M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.04
- Dividend yield
- –
- Free cash flow yield
- -29.81%
Fundamentals
- Net income
- -$18.60M
- EPS, diluted
- -$0.27
- Free cash flow
- -$19.60M
- Book value per share
- $0.94
- Diluted shares
- 67M
Trading
- Previous close
- $1.03
- Open
- $1.04
- Day's range
- $0.95 – $1.05
- Volume
- 1,163,780
- Average volume (20 days)
- 921,899
- Beta (5 years)
- 1.47
- 52-week range
- $0.93 – $2.85
- RSI (14 days)
- 40.3
- Volatility (1 year)
- 69.6%
- Relative volume
- 1.65×
- WACC
- 12.5%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | MBOT | S&P 500 | Difference | MBOT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.0% | -3.0% | −1.0 pts | ||
| 3 months | -41.7% | -2.8% | −39.0 pts | ||
| Year to date | -51.1% | +11.5% | −62.6 pts | ||
| 1 year | -50.8% | +13.5% | −64.3 pts | ||
| 3 years | -27.0% | +77.7% | −104.7 pts | -9.9% | +21.1% |
| 5 years | -85.9% | +72.6% | −158.5 pts | -32.4% | +11.5% |
| 10 years | -99.3% | +308.2% | −407.5 pts | -39.5% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Microbot Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
About Microbot Medical
Surgical & Medical Instruments & Apparatus
Microbot Medical Inc. is a medical device company that researches, designs, and develops robotic endoluminal surgical systems. The company focuses on developing its proprietary robotic surgical platform, known as the LIBERTY Endovascular Robotic Surgical System, which is designed for use in endovascular procedures. Microbot aims to serve healthcare providers, medical facilities, and surgical specialists conducting minimally invasive interventions.
Company profile, executives and historyMicrobot Medical stock: common questions
What is Microbot Medical's stock price?
MBOT closed at $0.98 on Nov 13, 2026, down 4.98% on the day. Over the past 52 weeks it traded between $0.93 and $2.85.
What is Microbot Medical's market cap?
Microbot Medical was worth $65.73M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is MBOT's P/E ratio?
Microbot Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.27), so it has no meaningful P/E ratio.
Does Microbot Medical pay a dividend?
No. Microbot Medical has not paid a cash dividend over the last twelve months.
How has MBOT stock performed over the past year?
Including dividends, MBOT returned -50.8% over the past year, against +13.5% for the S&P 500.
How many MBOT shares are sold short?
6M shares were sold short at the latest FINRA report, 9.44% of the float, or 7.8 days of average trading volume.
Who are Microbot Medical's competitors?
Companies most similar to Microbot Medical by business, industry and size include GUTS, PYPD, SSII, PRCT, LNSR.
See a number that looks wrong?